The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).
B. M. William
No relevant relationships to disclose
F. R. Loberiza
No relevant relationships to disclose
V. Whalen
No relevant relationships to disclose
P. J. Bierman
No relevant relationships to disclose
G. Bociek
No relevant relationships to disclose
J. Vose
Research Funding - Allos Therapeutics; Astellas Pharma; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Millennium; Novartis; Pharmacyclics; Rigel
J. O. Armitage
Consultant or Advisory Role - Biogen Idec; Eisai; Seattle Genetics; ZIOPHARM Oncology